Skip to main content

and
  1. Article

    Open Access

    Distinct mesenchymal cell states mediate prostate cancer progression

    In the complex tumor microenvironment (TME), mesenchymal cells are key players, yet their specific roles in prostate cancer (PCa) progression remain to be fully deciphered. This study employs single-cell RNA s...

    Hubert Pakula, Mohamed Omar, Ryan Carelli, Filippo Pederzoli in Nature Communications (2024)

  2. Article

    Open Access

    Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy

    Bladder mechanical properties are critical for organ function and tissue homeostasis. Therefore, alterations of tissue mechanics are linked to disease onset and progression. This study aims to characterize the...

    Laura Martinez-Vidal, Claudia Testi, Emanuele Pontecorvo in Scientific Reports (2024)

  3. Article

    Open Access

    Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia

    Molecular mechanisms associated with human germ cell aplasia in infertile men remain undefined. Here we perform single-cell transcriptome profiling to highlight differentially expressed genes and pathways in e...

    Massimo Alfano, Anna Sofia Tascini, Filippo Pederzoli in Nature Communications (2021)

  4. Article

    Open Access

    Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia

    The lack of clinically-reliable biomarkers makes impossible to predict sperm retrieval outcomes at testicular sperm extraction (TESE) in men with non-obstructive azoospermia (NOA), resulting in up to 50% of un...

    Massimo Alfano, Eugenio Ventimiglia, Irene Locatelli in Scientific Reports (2017)

  5. Article

    Open Access

    Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone

    To assess the rate and predictors of clinically meaningful improvements (CMI) in patients with lower urinary tract symptoms (LUTS) treated with either silodosin (SIL) alone or with a combination of SIL+ sereno...

    Luca Boeri, Paolo Capogrosso, Eugenio Ventimiglia, Walter Cazzaniga in Scientific Reports (2017)